The current situation and prospects of the application of intelligent diagnosis and treatment technology in the general surgery / 中华外科杂志

With the development of the times, a series of innovative intelligent diagnosis and treatment techniques have emerged, providing new strategies and means for disease diagnosis and treatment, which is helpful for promoting the development of general surgery in China. This article, combined with relevant literature at home and abroad, reviews the application of digital medical intelligent diagnosis and treatment technologies in general surgery,such as three-dimensional visualization,three-dimentional printing, mixed reality, molecular fluorescence imaging, artificial intelligence-imaging omics, abdominal surgery navigation and photoacoustic imaging. Three-dimentional visualization has changed the traditional "two-dimensional" disease diagnosis and treatment mode; three-dimentional printing of three-dimentional images is a leap-forward transition to stereoscopic physical models; mixed reality has broken the boundary between the digital virtual world and the physical real world, bringing technological innovation to traditional surgery; Indocyanine green molecular fluorescence imaging has achieved tumor boundary definition, micro or metastatic lesion detection and intraoperative real-time navigation at the molecular and cellular level; artificial intelligence-imaging omics can improve the accuracy of disease diagnosis and predict risk and efficacy; abdominal surgical navigation can improve the accuracy and safety of the operation; high precision-cross-scale photoacoustic microscopy can define the tumor boundary from the molecular, cellular and microvascular levels to guide the precise resection of the tumor; finally, this paper looks forward to the new direction of general surgery diagnosis and treatment represented by digital medicine and artificial intelligence.

Development of targeted therapies in small cell lung cancer / 中国药理学通报

Small cell lung cancer(SCLC) is a type of neuroendcorine cancer with high growth fraction, early metastatic spread and poor prognosis, accounting for approximately 15％ of all newly diagnosed lung cancer cases.Patients with SCLC are generally treated with platinum-based chemotherapy in combination with radiotherapy.Despite good responses to chemotherapy in the early stage of treatment, patients develop drug resistance and recurrence soon.There has been limited success with the targeted approaches in clinical trials completed in the past several years.Novel targeted and more effective treatment strategies for SCLC are in urgent need With increasing translational research and a better understanding of the molecular basis of small cell lung cancer, a number of new targeted drugs such as kinase inhibitors, angiogenesis inhibitors, apoptosis inducers, proteasome inhibitors, epigenetic regulators, immune checkpoint inhibitors have been developed and investigated in various preclinical studies.Some of them have entered clinical trials.At the same time, a number of novel treatment strategies such as immunotherapy and combination treatment receive attention.This review summarizes potentially molecular targeted therapies that have been developed and employed recently, and ongoing and future clinical trials in attempt to improve patient outcomes in SCLC, and meanwhile to invite future potential SCLC new treatment strategies.

Alternative Therapies for PKU

Abstract The phenylalanine (PHE)-restricted diet has improved in quality and diversity over time and has proven to be effective in all patients. Nevertheless, this treatment imposes a heavy social and economic burden to patient and family and impacts quality of life. Sustained adherence to PHE restriction is difficult to maintain. Moreover, even patients with phenylketonuria (PKU) with normal intelligence quotient (IQ) have lower IQ than matched individuals without PKU and can have deficits in multiple other aspects of neuropsychological function, including cognitive and executive function, working memory. They can also have behavior problems, depression, and low self-esteem. In recent years, alternative treatments for PKU have been developed and their use has been indicated for some patients who are candidates for options besides traditional treatment. Sapropterindihydrochloride, large neutral amino acids, and glycomacropeptide are alternative treatment options in use for selected patients. The aim of this article is to review the current knowledge of these new approaches to PKU treatment.